ST昌九(600228.SH):推選盧岐擔任董事長 聘任李季擔任總經理
格隆匯5月19日丨ST昌九(600228.SH)公佈,公司董事會於2020年5月18日收到公司董事長李季、總經理盧岐的書面辭職報告。因工作調整需要,李季申請辭去公司董事長的職務,盧岐申請辭去公司總經理的職務,根據《公司法》和《公司章程》的相關規定,上述辭職報告自送達公司董事會之日起生效。
根據公司發展需要,公司第七屆董事會第十五次會議審議通過《關於推選公司董事長的議案》、《關於聘任公司總經理的議案》,同意推選盧岐擔任公司第七屆董事會董事長,同意聘任李季擔任公司總經理。盧岐、李季職務變動系公司工作需要正常調整,不會影響公司生產經營及重大事項正常推進。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.